These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20872925)

  • 1. Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study.
    Wetherell JL; Stoddard JA; White KS; Kornblith S; Nguyen H; Andreescu C; Zisook S; Lenze EJ
    Int J Geriatr Psychiatry; 2011 Aug; 26(8):869-75. PubMed ID: 20872925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.
    Wetherell JL; Petkus AJ; White KS; Nguyen H; Kornblith S; Andreescu C; Zisook S; Lenze EJ
    Am J Psychiatry; 2013 Jul; 170(7):782-9. PubMed ID: 23680817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study.
    Schneier FR; Belzer KD; Kishon R; Amsel L; Simpson HB
    J Nerv Ment Dis; 2010 Jun; 198(6):458-61. PubMed ID: 20531128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
    Rosnick CB; Wetherell JL; White KS; Andreescu C; Dixon D; Lenze EJ
    J Consult Clin Psychol; 2016 Apr; 84(4):345-52. PubMed ID: 26881447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.
    Lenze EJ; Rollman BL; Shear MK; Dew MA; Pollock BG; Ciliberti C; Costantino M; Snyder S; Shi P; Spitznagel E; Andreescu C; Butters MA; Reynolds CF
    JAMA; 2009 Jan; 301(3):295-303. PubMed ID: 19155456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
    Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
    Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive-behavior therapy for late-life generalized anxiety disorder: literature overview].
    Chojnacka M
    Psychiatr Pol; 2009; 43(5):557-69. PubMed ID: 20214097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WCA recommendations for the long-term treatment of generalized anxiety disorder.
    Allgulander C; Bandelow B; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):53-61. PubMed ID: 14767398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
    Grant JE; Potenza MN
    Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.
    Lenze EJ; Goate AM; Nowotny P; Dixon D; Shi P; Bies RR; Lotrich FK; Rollman BL; Shear MK; Thompson PA; Andreescu C; Pollock BG
    J Clin Psychopharmacol; 2010 Dec; 30(6):672-7. PubMed ID: 21105279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.
    Dunlop BW; LoParo D; Kinkead B; Mletzko-Crowe T; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
    Am J Psychiatry; 2019 Apr; 176(4):275-286. PubMed ID: 30764648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
    Davidson JR; Bose A; Wang Q
    J Clin Psychiatry; 2005 Nov; 66(11):1441-6. PubMed ID: 16420082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.